S. Samar Hasnain

S. Samar Hasnain FRSC is the Max Perutz professor of Molecular Biophysics at the University of Liverpool. He is current editor in chief for the Journal of Applied Crystallography. In 1991 he became a Fellow of the Institute of Physics and in 2002 he became a Fellow of the Royal Society of Chemistry. Additionally, in 1997 he became a Fellow of the Third World Academy of Sciences and in 2011 a Fellow of the Society of Biology. He is also currently editor-in-chief for the Journal of Synchrotron Radiation.[1][2][3]

Background

In 1970 Hasnain earned a Bachelor of Science (Honours) an M.Sc. in 1972 and a Ph.D. in 1977. His research areas include neurodegenerative diseases, methodical drug discovery, protein crystallography, and synchrotron radiation.[3]

Research

Hasnain led a team of researchers who identified TDP-43 mutant proteins as potentially significant factors relating to motor neuron diseases via neurodegeneration.[4][5] He has also conducted other neurological studies.[6]

References

  1. ↑ Editor-in-chief. "Editorial board of Journal of Applied Crystallography" (Web page). International Union of Crystallography. Retrieved 30 April 2014.
  2. ↑ Editor-in-chief. "Editorial board of Journal of Synchrotron Radiation" (Web page). International Union of Crystallography. Retrieved 30 April 2014.
  3. 1 2 Molecular Biophysics Group. "Prof. S. Samar Hasnain" (Biography page). University of Liverpool. Retrieved 30 April 2014.
  4. ↑ Samantha, Price (4 March 2014). "TDP-43: A protein that lingers on.." (Web page). Motor Neurone Disease Association. doi:10.1073/pnas.1317317111. Retrieved 30 April 2014.
  5. ↑ Austin, J. A.; Wright, G. S. A.; Watanabe, S.; Grossmann, J. G.; Antonyuk, S. V.; Yamanaka, K.; Hasnain, S. S. (2014). "Disease causing mutants of TDP-43 nucleic acid binding domains are resistant to aggregation and have increased stability and half-life". Proceedings of the National Academy of Sciences. 111 (11): 4309. Bibcode:2014PNAS..111.4309A. doi:10.1073/pnas.1317317111. Retrieved 30 April 2014.
  6. ↑ Antonyuk, S. V.; Trevitt, C. R.; Strange, R. W.; Jackson, G. S.; Sangar, D.; Batchelor, M.; Cooper, S.; Fraser, C.; Jones, S.; Georgiou, T.; Khalili-Shirazi, A.; Clarke, A. R.; Hasnain, S. S.; Collinge, J. (2009). "Crystal structure of human prion protein bound to a therapeutic antibody" (PDF). Proceedings of the National Academy of Sciences. 106 (8): 2554. Bibcode:2009PNAS..106.2554A. doi:10.1073/pnas.0809170106. Retrieved 30 April 2014.
This article is issued from Wikipedia - version of the 9/5/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.